PreSize® Neurovascular is launched in the NHS
Oxford Heartbeat's software PreSize® Neurovascular is on track to be introduced within the NHS.
News & Insights
Publications
Flow diverter deployment planning using PreSize® Neurovascular medical software
Presentation at the 12th ESMINT Congress
- 10/09/2020
Flow diverter deployed length prediction by computational simulation in PreSize® Neurovascular medical software: a retrospective study
Presentation at the ABC-WIN Seminar
- 17/01/2020
Virtual flow diverter treatment planning: The effect of device placement on bifurcation aneurysm haemodynamics
Special issue article in the Journal of Engineering in Medicine
- 25/10/2016
Towards predicting patient-specific flow diverter treatment outcomes for bifurcation aneurysms: from implantation rehearsal to virtual angiograms
Published in the Annals of Biomedical Engineering
- 04/08/2015
Comparison and calibration of a real-time virtual stenting algorithm using Finite Element Analysis and Genetic Algorithms
Published in Computer Methods in Applied Mechanics and Engineering
- 22/04/2015
Personalising flow diverter intervention for cerebral aneurysms: from computational hemodynamics to biochemical modelling
Published in the International Journal for Numerical Methods in Biomedical Engineering
- 07/07/2014
Which Spring is the Best? Comparison of Methods for Virtual Stenting
Published in IEEE Transactions on Biomedical Engineering
- 14/06/2014
Interview with Enterprising Oxford
Our CEO Katerina shares her insights on how entrepreneurship has enabled her to contribute to medicine.
Oxford Heartbeat wins AI in Health and Care Award
Oxford Heartbeat's software PreSize® Neurovascular is on track to be introduced within the NHS.
Interview with the Royal Academy of Engineering
Our CEO Katerina, a Royal Academy of Engineering Fellow, speaks about the joys and challenges of entrepreneurship.
Feature on CE marking with DigitalHealth.London
Acquiring CE marking for novel medical devices is often a complex process.
Oxford Heartbeat is awarded CE marking
PreSize® Neurovascular is now deemed ready for market release at all hospitals across the EU and UK.
